Powered by

Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes

Jan 02, 2019 - PR Newswire
Board and Executive Moves

PR Newswire


- Mark H.N. Corrigan, MD to Succeed William Hunter, MD as Chief Executive Officer by the End of the First Quarter 2019 -

- Dr. Hunter to Remain a Member of the Board of Directors -

- Chief Financial Officer, Justin Renz, Appointed President -

- Vanda De Cian, MD, to Join the Board of Directors -

 Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercial...